BK7508 Pharmaceutical Companies
Market Closed 04-17 16:00:00 AEST
555.02
+0.38
+0.07%
High558.57Low550.35Vol136.06M
Open555.95D1 Closing554.64Amplitude1.48%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O213.71MT/O Rate--Tradable Shares0.00
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Surge in Friday Trading; Up 5% for Week
MT Newswires Live  ·  04-17 22:36
Asian Equities Traded in the US as American Depositary Receipts Surge in Friday Trading; Up 5% for Week
Immuron Q3 sales rise 16% to AUD 1.5 million
Reuters  ·  04-17 18:01
Immuron Q3 sales rise 16% to AUD 1.5 million
Immuron Double Digit 3Q Sales Growth
THOMSON REUTERS  ·  04-17 18:00
Immuron Double Digit 3Q Sales Growth
OSL Group Expands RWA Ecosystem, Becomes First in Hong Kong to Dual-List Matrixdock Gold and Silver Tokens
prnewswire  ·  04-17 17:11
OSL Group Expands RWA Ecosystem, Becomes First in Hong Kong to Dual-List Matrixdock Gold and Silver Tokens
BUZZ-Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Reuters  ·  04-17 11:40
BUZZ-Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
BUZZ-Australia's Immuron jumps on upbeat quarterly sales growth
Reuters  ·  04-17 10:54
BUZZ-Australia's Immuron jumps on upbeat quarterly sales growth
Proteomics International Laboratories Says Restructure, Executive Appointment And Board Update
Reuters  ·  04-17 09:43
Proteomics International Laboratories Says Restructure, Executive Appointment And Board Update
BRIEF-Immuron Global Q3 Sales AUD$1.5 Million
Reuters  ·  04-17 09:06
BRIEF-Immuron Global Q3 Sales AUD$1.5 Million
Orthocell Says First Surgical Case Using Nerve Repair Product in US Department of Defense Hospital Network Completed
MT Newswires Live  ·  04-17 07:31
Orthocell Says First Surgical Case Using Nerve Repair Product in US Department of Defense Hospital Network Completed
Immuron Ltd - Global Q3 Sales AUD$1.5 Mln
THOMSON REUTERS  ·  04-17 07:30
Immuron Ltd - Global Q3 Sales AUD$1.5 Mln
Proteomics International Laboratories Ltd - Cuts 25% of Positions, Expects Over a$1 Mln Annualised Cost Savings
THOMSON REUTERS  ·  04-17 07:21
Proteomics International Laboratories Ltd - Cuts 25% of Positions, Expects Over a$1 Mln Annualised Cost Savings
Proteomics International Laboratories Ltd-Restructure, Executive Appointment and Board Update
THOMSON REUTERS  ·  04-17 07:21
Proteomics International Laboratories Ltd-Restructure, Executive Appointment and Board Update
Proteomics International Laboratories Ltd - Appoints Tim Luscombe as Chief Financial Officer
THOMSON REUTERS  ·  04-17 07:21
Proteomics International Laboratories Ltd - Appoints Tim Luscombe as Chief Financial Officer
Orthocell Ltd-First Surgical Use of Remplir in US Department of Defense
THOMSON REUTERS  ·  04-17 07:01
Orthocell Ltd-First Surgical Use of Remplir in US Department of Defense
ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep
The West Australian  ·  04-17 06:27
ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep
Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline
Simply Wall St.  ·  04-16 22:08
Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline
Immutep files beneficial ownership Form 3 for director Elisabeth Amanda Boyce
Reuters  ·  04-16 18:06
Immutep files beneficial ownership Form 3 for director Elisabeth Amanda Boyce
BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Reuters  ·  04-16 16:03
BRIEF-Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Orthocell wins approval to sell Remplir across US DoD, VA hospital networks
Reuters  ·  04-16
Orthocell wins approval to sell Remplir across US DoD, VA hospital networks
BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Reuters  ·  04-16
BUZZ-Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions

Introduction

Company Name.
BK7508
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--